Ever Supreme Bio Technology Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Taichung Taiwan (2016)

Organization Overview

First Clinical Trial
2019
NCT04056819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ever-Supreme Biotechnology | Ever Supreme Bio Technology Co., Ltd.